Heart, Lung and Circulation
Volume 15, Issue 5 , Pages 291-296 , October 2006

Final Myocardial Blush Grade Predicts Troponin I Elevation in Unstable Angina Patients Undergoing Percutaneous Intervention

Received 19 May 2005 ,Revised 4 April 2006 ,Accepted 19 May 2006.

References 

  1. Braunwald E, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article. J Am Coll Cardiol. 2002;40(7):1366–1374
  2. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase 1 findings. N Eng J Med. 1985;312:932–936
  3. Stone GW, Brodie BR, Griffin JJ, Morice MC, Constantini C, St Goar FG, et al. A prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30 day results of the PAMI Stent Pilot Trial. J Am Coll Cardiol. 1998;31:23–30
  4. Roe MT, Ohman EM, Maas ACP, Christenson RH, Mahaffey KW, Granger CB, et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol. 2001;37:9–18
  5. Van’t Hof AWJ, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction-myocardial blush grade. Circulation. 1998;97:2302–2306
  6. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125–130
  7. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol. 2002;39:591–597
  8. Kosuge M, Kimura K, Ishikawa T, Endo T, Sugano T, Hibi K, et al. Reliability of resolution of ST-segment elevation after coronary reperfusion in predicting myocardial salvage in anterior wall acute myocardial infarction. Am J Cardiol. 2002;90(3):227–232
  9. Haager PK, Christott P, Heussen N, Lepper W, Hanrath P, Hoffmann R. Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion. J Am Coll Cardiol. 2003;41(4):532–538
  10. Bolognese L, Ducci K, Angioli P, Falsini G, Liistro F, Baldassarre S, et al. Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes. Circulation. 2004;110(27):1592–1597
  11. SPSS Version 11.5.1. Chicago, IL: SPSS Inc.; 2002.
  12. Chamuleau SA, Siebes M, Meuwissen M, Koch KT, Spaan JA, Piek JJ. Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease. Am J Physiol Heart Circ Physiol. 2003;285(5):H2194–H2200
  13. Shah PK. Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. Prog Cardiovasc Dis. 2002;44(5):357–368
  14. Mintz GS, Maehara A, Bui AB, Weissman NJ. Multiple versus single coronary plaque ruptures detected by intravascular ultrasound in stable and unstable angina pectoris and in acute myocardial infarction. Am J Cardiol. 2003;91(11):1333–1335
  15. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303(16):897–902
  16. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van’t Hof AW, Hoorntje JC, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 2002;23(14):1112–1117
  17. Sakuma T, Sklenar J, Leong-Poi H, Goodman NC, Glover DK, Kaul S. Molecular imaging identifies regions with microthromboemboli during primary angioplasty in acute coronary thrombosis. J Nucl Med. 2004;45(7):1194–1200
  18. Barcin C, Denktas AE, Lennon RJ, Hammes L, Higano ST, Holmes DR, et al. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter Cardiovasc Interv. 2004;61(4):484–491
  19. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the “no-refow” phenomenon. Circulation. 1996;93:223–228
  20. De Lemos JA, Antman EM, Gibson M, McCabe CH, Giugliano RP, Murphy SA, et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation myocardial infarction: observations from the TIMI-14 trial. Circulation. 2000;201:239–243
  21. Stoupakis G, Orlando J, Kalia H, Skurnick J, Saric M, Arora R. Preservation of myocardial microcirculation during mechanical reperfusion for myocardial ischemia with either abciximab or eptifibatide. J Invasive Cardiol. 2003;15(9):476–480
  22. Kunichika H, Ben-Yehuda O, Lafitte S, Kunichika N, Peters B, DeMaria AN. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. J Am Coll Cardiol. 2004;43(2):276–283
  23. Suzuki H, Matsubara H, Koba S, Murakami M, Takeyama Y, Katagiri T. Clinical characteristics and follow-up in patients with microvascular angina. Circ J. 2002;66(7):691–695
  24. Bodi V, Sanchis J, Llacer A, Lopez-Lereu MP, Losada A, Pellicer M, et al. Significance of exercise-induced ST segment elevation in Q leads in patients with a recent myocardial infarction and an open infarct-related artery: analysis with angiography, intracoronary myocardial contrast echocardiography and cardiac magnetic resonance. Int J Cardiol. 2005;103:85–91
  25. Drzewiecka-Gerber A, Drzewiecki J, Wita K, Krauze J, Jaklik A, Trusz-Ghiza M, et al. Prognostic value of troponin I after elective percutaneous coronary interventions. Cardiol Pol. 2004;61(8):117–126
  26. Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, et al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J. 2003;145(3):522–528
  27. Granger CB, et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation. 2003;108(10):1184–1190

PII: S1443-9506(06)00119-3

doi: 10.1016/j.hlc.2006.05.008

Heart, Lung and Circulation
Volume 15, Issue 5 , Pages 291-296 , October 2006

Article Tools

* Image Usage & Resolution